XRAY vs NNNN

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 24, 2026

XRAY

57.2
AI Score
VS
XRAY Wins

NNNN

38.7
AI Score

Investment Advisor Scores

XRAY

57score
Recommendation
HOLD

NNNN

39score
Recommendation
SELL

AI Analyst Insights

Detailed Metrics Comparison

Metric XRAY NNNN Winner
Forward P/E 7.4627 0 Tie
PEG Ratio 0.746 0 Tie
Revenue Growth -4.1% 73.9% NNNN
Earnings Growth 15.2% 2.8% XRAY
Tradestie Score 57.2/100 38.7/100 XRAY
Profit Margin -15.0% 74.1% NNNN
Beta 1.00 1.00 Tie
AI Recommendation HOLD SELL XRAY

Relative Price Performance (Last 90 Days)

XRAY 1M: -14.2% · 3M: +10.0% NNNN 1M: -30.1% · 3M: -77.5%

Current Technical Phase

XRAY

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 36

RSI (14): 36.2 · Price: $10.92

NNNN

Markdown
Sell / avoid

Price below a falling SMA50 (slope -39.0%), weak momentum, RSI 28

RSI (14): 28.1 · Price: $6.81

Fundamentals Snapshot

Metric XRAY NNNN
Market Cap
Forward P/E 7.2 0.0
Trailing P/E 52.4
Revenue (TTM)
Revenue Growth 0.0% 0.7%
Gross Margin 0.5% 0.9%
Operating Margin 0.1% 0.6%
EPS -2.71 0.14
Dividend Yield 0.03%

Frequently Asked Questions

Based on our detailed analysis, XRAY is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.